SCHEMBL25577622

SCHEMBL25577622

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2N(c2ccc(-c3ccc4oc5ccccc5c4c3)cc2)c2ccccc2-c2cccc3c2oc2ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.40
▸ PLA2G2A P14555 4/20 0.35
▸ PLA2G4A P47712 4/20 0.35
▸ PLA2G10 O15496 1/20 0.34
▸ GGPS1 O95749 1/20 0.33
▸ PRKDC P78527 5/20 0.32
▸ PIM1 P11309 1/20 0.32
▸ CSNK2A2 P19784 1/20 0.32
▸ CSNK2B P67870 1/20 0.32
▸ PIM3 Q86V86 1/20 0.32
▸ PIM2 Q9P1W9 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ HSP90AB1 P08238 1/20 0.32
▸ PTGES2 Q9H7Z7 1/20 0.32
▸ PTPRF P10586 1/20 0.31
▸ PTPN2 P17706 1/20 0.31
▸ PTPN1 P18031 1/20 0.31
▸ NPC1 O15118 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25579331 0.95 ALOX5 (0.42) ALOX5PLA2G2APLA2G4APLA2G10GGPS1
SCHEMBL25577615 0.94 ALOX5 (0.40) ALOX5PLA2G2APLA2G4AGGPS1PRKDC
SCHEMBL25577430 0.94 ALOX5 (0.39) ALOX5PLA2G2APLA2G4APLA2G10GGPS1
SCHEMBL25577652 0.94 ALOX5 (0.44) ALOX5PLA2G2APLA2G4APLA2G10GGPS1
SCHEMBL25579372 0.94 ALOX5 (0.41) ALOX5GGPS1PRKDCPTGES2MAPT
SCHEMBL25579387 0.94 ALOX5 (0.41) ALOX5GGPS1PRKDCPTGES2MAPT
SCHEMBL25577289 0.93 ALOX5 (0.40) ALOX5GGPS1PRKDCPTGES2NPC1
SCHEMBL25579263 0.93 PLA2G2A (0.38) ALOX5PLA2G2APLA2G4APLA2G10PRKDC
SCHEMBL25579357 0.93 PLA2G2A (0.38) ALOX5PLA2G2APLA2G4APLA2G10PRKDC
SCHEMBL25577627 0.92 ALOX5 (0.44) ALOX5GGPS1PRKDCPIM1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 ALOX5 1615/4885PLA2G2A 2335/4885PLA2G4A 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback